• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病通过 Cebpa 失调抑制 Gr-1+ 髓样细胞成熟。

Diabetes Inhibits Gr-1+ Myeloid Cell Maturation via Cebpa Deregulation.

机构信息

The Healing Foundation Centre, Faculty of Life Sciences, University of Manchester, Manchester, U.K.

Faculty of Medical and Human Sciences, University of Manchester, Manchester, U.K.

出版信息

Diabetes. 2015 Dec;64(12):4184-97. doi: 10.2337/db14-1895. Epub 2015 Aug 31.

DOI:10.2337/db14-1895
PMID:26324181
Abstract

Recruitment of innate immune cells from the bone marrow (BM) to an injury site is required for effective repair. In diabetes, this process is altered, leading to excessive recruitment and retention of dysfunctional myeloid cells that fail to promote angiogenesis, prolong inflammation, and block healing. The aberrant myeloid phenotype is partially mediated by stable intrinsic changes to developing cells in the BM that are induced by the diabetic (db) environment, but the exact mechanisms remain largely unknown. Here, we show that the db-derived Gr-1(+)CD11b(+) immature myeloid population has widespread misexpression of chromatin-remodeling enzymes and myeloid differentiation factors. Crucially, diabetes represses transcription of the key myeloid transcription factor CEBPA via diminished H3 Lys 27 promoter acetylation, leading to a failure in monocyte and granulocyte maturation. Restoring Cebpa expression by granulocyte colony-stimulating factor reverses the db phenotype and rescues myeloid maturation. Importantly, our data demonstrate a possible link between myeloid cell maturation and chronic inflammation.

摘要

招募骨髓中的先天免疫细胞到损伤部位是有效修复所必需的。在糖尿病中,这个过程发生了改变,导致功能失调的髓样细胞过度募集和滞留,这些细胞无法促进血管生成、延长炎症反应并阻碍愈合。这种异常的髓样表型部分是由糖尿病(db)环境诱导的骨髓中发育中的细胞的稳定内在变化介导的,但确切的机制仍在很大程度上未知。在这里,我们表明,db 来源的 Gr-1(+)CD11b(+)未成熟髓样细胞群体广泛表达染色质重塑酶和髓样分化因子。至关重要的是,糖尿病通过减少 H3 Lys 27 启动子乙酰化来抑制关键髓样转录因子 CEBPA 的转录,导致单核细胞和粒细胞成熟失败。通过粒细胞集落刺激因子恢复 Cebpa 表达可逆转 db 表型并挽救髓样细胞成熟。重要的是,我们的数据表明髓样细胞成熟与慢性炎症之间可能存在联系。

相似文献

1
Diabetes Inhibits Gr-1+ Myeloid Cell Maturation via Cebpa Deregulation.糖尿病通过 Cebpa 失调抑制 Gr-1+ 髓样细胞成熟。
Diabetes. 2015 Dec;64(12):4184-97. doi: 10.2337/db14-1895. Epub 2015 Aug 31.
2
Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.Runx1 缺失或显性抑制通过保守的启动子和远端增强子位点减少 Cebpa 转录,有利于单核细胞生成而不是粒细胞生成。
Blood. 2012 May 10;119(19):4408-18. doi: 10.1182/blood-2011-12-397091. Epub 2012 Mar 26.
3
Granulopoiesis requires increased C/EBPα compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells.与单核细胞生成相比,粒细胞生成需要增加的C/EBPα,这与未成熟的表达G-CSF受体的细胞中Cebpa升高相对于表达M-CSF受体的细胞相关。
PLoS One. 2014 Apr 21;9(4):e95784. doi: 10.1371/journal.pone.0095784. eCollection 2014.
4
Hoxa3 promotes the differentiation of hematopoietic progenitor cells into proangiogenic Gr-1+CD11b+ myeloid cells.Hoxa3 促进造血祖细胞向促血管生成 Gr-1+CD11b+ 髓样细胞分化。
Blood. 2011 Jan 20;117(3):815-26. doi: 10.1182/blood-2009-12-259549. Epub 2010 Oct 25.
5
In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.体内删除Cebpa +37 kb增强子可显著降低髓系祖细胞中Cebpa mRNA水平,但不影响非造血组织中的水平,从而损害粒细胞生成。
PLoS One. 2016 Mar 3;11(3):e0150809. doi: 10.1371/journal.pone.0150809. eCollection 2016.
6
HoxA9 binds and represses the Cebpa +8 kb enhancer.HoxA9 结合并抑制 Cebpa+8kb 增强子。
PLoS One. 2019 May 23;14(5):e0217604. doi: 10.1371/journal.pone.0217604. eCollection 2019.
7
EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements.EVI1通过与两个远下游调控元件结合,对Cebpa进行转录抑制,从而干扰髓系成熟。
J Biol Chem. 2016 Jun 24;291(26):13591-607. doi: 10.1074/jbc.M115.708156. Epub 2016 Apr 21.
8
Increased expression of TLR9 associated with pro-inflammatory S100A8 and IL-8 in diabetic wounds could lead to unresolved inflammation in type 2 diabetes mellitus (T2DM) cases with impaired wound healing.糖尿病伤口中与促炎因子S100A8和白细胞介素-8相关的Toll样受体9(TLR9)表达增加,可能导致伤口愈合受损的2型糖尿病(T2DM)患者炎症持续不愈。
J Diabetes Complications. 2016 Jan-Feb;30(1):99-108. doi: 10.1016/j.jdiacomp.2015.10.002. Epub 2015 Oct 9.
9
C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia.C/EBPγ 失调导致急性髓系白血病分化阻滞。
J Clin Invest. 2012 Dec;122(12):4490-504. doi: 10.1172/JCI65102. Epub 2012 Nov 19.
10
Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-tetrahydrocannabinol in vivo: regulation of CCAAT/enhancer-binding protein α by microRNA-690.体内Δ9-四氢大麻酚诱导功能性髓系来源抑制细胞的独特 microRNA 表达谱和靶向生物学途径:microRNA-690 对 CCAAT/增强子结合蛋白α的调控。
J Biol Chem. 2013 Dec 27;288(52):36810-26. doi: 10.1074/jbc.M113.503037. Epub 2013 Nov 7.

引用本文的文献

1
Bioinformatical analysis and experimental validation of endoplasmic reticulum stress-related biomarker genes in type 2 diabetes mellitus.2型糖尿病中内质网应激相关生物标志物基因的生物信息学分析及实验验证
Front Genet. 2024 Nov 1;15:1445033. doi: 10.3389/fgene.2024.1445033. eCollection 2024.
2
The CEBPA-FGF21 regulatory network may participate in the T2DM-induced skeletal muscle atrophy by regulating the autophagy-lysosomal pathway.CEBPA-FGF21 调控网络可能通过调节自噬溶酶体通路参与 T2DM 诱导的骨骼肌萎缩。
Acta Diabetol. 2023 Nov;60(11):1491-1503. doi: 10.1007/s00592-023-02131-x. Epub 2023 Jul 1.
3
circRNAs May Be Involved in Dysfunction of Neutrophils of Type 2 Diabetic Mice through Regulation of Specific miRNAs.
环状RNA可能通过调控特定的微小RNA参与2型糖尿病小鼠中性粒细胞功能障碍。
Biomedicines. 2022 Dec 4;10(12):3129. doi: 10.3390/biomedicines10123129.
4
Macrophage Phenotypes in Normal and Diabetic Wound Healing and Therapeutic Interventions.巨噬细胞表型在正常和糖尿病伤口愈合及治疗干预中的作用。
Cells. 2022 Aug 5;11(15):2430. doi: 10.3390/cells11152430.
5
Emerging Roles of Myeloid-Derived Suppressor Cells in Diabetes.髓源性抑制细胞在糖尿病中的新作用
Front Pharmacol. 2021 Dec 16;12:798320. doi: 10.3389/fphar.2021.798320. eCollection 2021.
6
Dysregulation of macrophage development and phenotype in diabetic human macrophages can be rescued by Hoxa3 protein transduction.糖尿病患者巨噬细胞中巨噬细胞发育和表型的失调可以通过 Hoxa3 蛋白转导来挽救。
PLoS One. 2019 Oct 18;14(10):e0223980. doi: 10.1371/journal.pone.0223980. eCollection 2019.
7
Differentiation of diabetic foot ulcer-derived induced pluripotent stem cells reveals distinct cellular and tissue phenotypes.糖尿病足溃疡诱导多能干细胞的分化揭示了不同的细胞和组织表型。
FASEB J. 2019 Jan;33(1):1262-1277. doi: 10.1096/fj.201801059. Epub 2018 Aug 8.
8
Cytochrome P450 (CYP) epoxygenases as potential targets in the management of impaired diabetic wound healing.细胞色素 P450(CYP)环氧合酶作为改善糖尿病创面愈合障碍的潜在治疗靶点。
Lab Invest. 2017 Jul;97(7):782-791. doi: 10.1038/labinvest.2017.21. Epub 2017 Mar 20.
9
Plasticity of Myeloid Cells during Oral Barrier Wound Healing and the Development of Bisphosphonate-related Osteonecrosis of the Jaw.口腔屏障伤口愈合及双膦酸盐相关颌骨坏死发生过程中髓样细胞的可塑性
J Biol Chem. 2016 Sep 23;291(39):20602-16. doi: 10.1074/jbc.M116.735795. Epub 2016 Aug 11.
10
Enforced Expression of Hoxa3 Inhibits Classical and Promotes Alternative Activation of Macrophages In Vitro and In Vivo.Hoxa3的强制表达在体外和体内均抑制巨噬细胞的经典活化并促进其替代活化。
J Immunol. 2016 Aug 1;197(3):872-84. doi: 10.4049/jimmunol.1501944. Epub 2016 Jun 24.